Skip to main content
Signal8

Klobuchar Michael A

SEC insider (Form 3/4/5 filer). CIK 0001871957. Director at REVVITY, INC. (RVTY) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in MILLBRAE, CA.

Companies Klobuchar Michael A has filed insider reports for

  • REVVITY, INC. (RVTY): Director
  • Eikon Therapeutics, Inc. (EIKN): Officer, Chief Operating Officer
Klobuchar Michael A profile photo

Klobuchar Michael A

CIK: 0001871957

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

REVVITY, INC. logo
RVTY

REVVITY, INC.

Director
Eikon Therapeutics, Inc. logo
EIKN

Eikon Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • REVVITY, INC. logo
    RVTY

    REVVITY, INC.

    May 7, 2026
    Award
    Direct
    1K shares-
  • REVVITY, INC. logo
    RVTY

    REVVITY, INC.

    May 7, 2026
    Award
    Direct
    1.3K shares-
  • Eikon Therapeutics, Inc. logo
    EIKN

    Eikon Therapeutics, Inc.

    Mar 2, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    87.2K shares-
  • REVVITY, INC. logo
    RVTY

    REVVITY, INC.

    Apr 30, 2025
    Award
    Direct
    1.1K shares-
  • REVVITY, INC. logo
    RVTY

    REVVITY, INC.

    Apr 30, 2025
    Award
    Direct
    1.3K shares-

1-5 of 5